Filing Details
- Accession Number:
- 0001179110-14-015991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-03 17:16:29
- Reporting Period:
- 2014-10-30
- Filing Date:
- 2014-11-03
- Accepted Time:
- 2014-11-03 17:16:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | President, Ceo, Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Acquisiton | 2014-10-30 | 82,000 | $13.57 | 300,803 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Disposition | 2014-10-30 | 82,000 | $29.45 | 218,803 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Acquisiton | 2014-10-31 | 82,000 | $13.57 | 300,803 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Disposition | 2014-10-31 | 82,000 | $32.83 | 218,803 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-30 | 82,000 | $0.00 | 82,000 | $13.57 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-31 | 82,000 | $0.00 | 82,000 | $13.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 82,000 | 2007-06-01 | 2016-06-01 | No | 4 | M | Direct |
| 0 | 2007-06-01 | 2016-06-01 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $11.27 | 2008-05-30 | 2017-05-30 | 0 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 0 | 43,333 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-06-15 | 2018-08-13 | 0 | 76,875 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 146,800 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 56,700 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 105,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 50,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2024-05-14 | 0 | 21,250 | Direct |
| Common Stock | Stock Option (right to buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 85,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2017-05-30 | 0 | 85,000 | Direct |
| 2018-05-23 | 0 | 43,333 | Direct |
| 2018-08-13 | 0 | 76,875 | Direct |
| 2019-05-28 | 0 | 146,800 | Direct |
| 2019-05-28 | 0 | 56,700 | Direct |
| 2020-06-03 | 0 | 105,000 | Direct |
| 2022-05-22 | 0 | 50,000 | Direct |
| 2024-05-14 | 0 | 21,250 | Direct |
| 2024-05-14 | 0 | 85,000 | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable based on the achievement of certain performance milestones.
- Sale of Common Stock pursuant to reporting owner's 10b5-1 plan, which was adopted on February 4, 2014.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $29.4000 and $29.7600. The reporting person undertakes to provide detailed information regarding the number of shares sold at each separate price within the range set forth in this footnote upon request by the Commission staff, the issuer, or a security holder of the issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $32.8000 and $32.9800. The reporting person undertakes to provide detailed information regarding the number of shares sold at each separate price within the range set forth in this footnote upon request by the Commission staff, the issuer, or a security holder of the issuer.
Billionaire Hedge Funds
